Latest filing published 13 Nov 2007 for Theriva Biologics, Inc., €9,363.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Daniel J. Dorman: trading record in brief
Daniel J. Dorman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Theriva Biologics, Inc. and Sandston Corp. Over a trading history stretching from 22 December 2006 to 9 November 2007, the count stands at 3 filings.
The open-market record is one-sided, with 3 purchases worth €407k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2007: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €23k.
On 13 November 2007 came the latest disclosure, an open-market purchase for €9,363 in Theriva Biologics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel J. Dorman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,189 shares@ US$2.22Common StockSEC:0000890163-07-000685:0Canonical exit: 7 Feb 2008 (T+90)
- 247,542 shares@ US$2.22Common StockSEC:0000890163-07-000685:1Canonical exit: 7 Feb 2008 (T+90)
- 600,000 shares@ US$0.05Common StockSEC:0001209191-06-067150:0Canonical exit: 22 Mar 2007 (T+90)
3 of 3 declarations